Xuemei Peng

1.3k total citations · 1 hit paper
49 papers, 902 citations indexed

About

Xuemei Peng is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Xuemei Peng has authored 49 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 6 papers in Cancer Research. Recurrent topics in Xuemei Peng's work include Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Xuemei Peng is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (9 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). Xuemei Peng collaborates with scholars based in China, United States and United Kingdom. Xuemei Peng's co-authors include John L. Neumeyer, Jean M. Bidlack, Brian I. Knapp, Lin Huang, David M.J. Lilley, Severo Salvadori, Lawrence H. Lazarus, Gianfranco Balboni, Chunhui Qi and Linjuan Huang and has published in prestigious journals such as Nucleic Acids Research, Scientific Reports and Biochemical Journal.

In The Last Decade

Xuemei Peng

48 papers receiving 885 citations

Hit Papers

Antimicrobial peptide biological activity, delivery syste... 2025 2026 2025 10 20 30 40

Peers

Xuemei Peng
Woo Suk Koh South Korea
Jun Lin China
Yuefang Zhou United States
Nadezhda German United States
Xiaoqing Yu United States
Xuemei Peng
Citations per year, relative to Xuemei Peng Xuemei Peng (= 1×) peers Zhijing Wang

Countries citing papers authored by Xuemei Peng

Since Specialization
Citations

This map shows the geographic impact of Xuemei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Peng more than expected).

Fields of papers citing papers by Xuemei Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Peng. The network helps show where Xuemei Peng may publish in the future.

Co-authorship network of co-authors of Xuemei Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Peng. A scholar is included among the top collaborators of Xuemei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Peng. Xuemei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Shen, Jun, Yingxi Xu, Shuo Zhang, et al.. (2024). Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity. Cell stem cell. 31(7). 1003–1019.e9. 29 indexed citations
3.
Bu, Fan, Yuanlin He, Yuhang Luo, et al.. (2023). Ribocentre-switch: a database of riboswitches. Nucleic Acids Research. 52(D1). D265–D272. 8 indexed citations
4.
Cui, Zhenzhen, Cheng Lv, Xuemei Peng, et al.. (2023). Design, synthesis, and biological evaluation of a series of indolone derivatives as novel FLT3 inhibitors for the treatment of acute myeloid leukemia. Bioorganic Chemistry. 138. 106645–106645. 3 indexed citations
5.
Deng, Jie, Xuemei Peng, Jia Wang, et al.. (2023). Structure and ion-dependent folding of k-junctions. RNA. 29(9). 1411–1422. 3 indexed citations
6.
Peng, Xuemei, et al.. (2023). Crystal structures of the NAD+-II riboswitch reveal two distinct ligand-binding pockets. Nucleic Acids Research. 51(6). 2904–2914. 18 indexed citations
7.
Li, Huanxiu, et al.. (2023). Interspecific rootstocks improve the low-temperature resistance of bitter gourd through sucrose and nitrogen metabolism regulation. Acta Physiologiae Plantarum. 45(8). 7 indexed citations
8.
Peng, Xuemei, et al.. (2023). Chaihu-Longgu-Muli decoction improves sleep disorders by restoring orexin-A function in CKD mice. Frontiers in Endocrinology. 14. 4 indexed citations
9.
Deng, Jie, Xuemei Peng, Yuanlin He, et al.. (2022). Ribocentre: a database of ribozymes. Nucleic Acids Research. 51(D1). D262–D268. 17 indexed citations
10.
Deng, Jie, Timothy J. Wilson, Jia Wang, et al.. (2022). Structure and mechanism of a methyltransferase ribozyme. Nature Chemical Biology. 18(5). 556–564. 32 indexed citations
11.
Li, Pu, Jing Shi, Lijing Zhou, et al.. (2021). Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion. Frontiers in Microbiology. 12. 620322–620322. 6 indexed citations
12.
Shen, Peng, Aimin Li, Ziyan Zhang, et al.. (2021). CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics. 11(16). 8112–8128. 37 indexed citations
13.
Cheng, Chao, Wenmin Li, Xuemei Peng, et al.. (2021). miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis. Molecular Therapy — Methods & Clinical Development. 20. 615–624. 13 indexed citations
14.
Guerrero, Miguel, Mariangela Urbano, Xuemei Peng, et al.. (2013). Discovery, design and synthesis of a selective S1P3 receptor allosteric agonist. Bioorganic & Medicinal Chemistry Letters. 23(23). 6346–6349. 13 indexed citations
15.
Balboni, Gianfranco, Severo Salvadori, Ewa D. Marczak, et al.. (2010). Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic. European Journal of Medicinal Chemistry. 46(2). 799–803. 10 indexed citations
16.
Peng, Xuemei, Brian I. Knapp, Jean M. Bidlack, & John L. Neumeyer. (2007). High-affinity carbamate analogues of morphinan at opioid receptors. Bioorganic & Medicinal Chemistry Letters. 17(6). 1508–1511. 10 indexed citations
17.
Peng, Xuemei, Brian I. Knapp, Jean M. Bidlack, & John L. Neumeyer. (2007). In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors. Bioorganic & Medicinal Chemistry. 15(12). 4106–4112. 9 indexed citations
18.
Peng, Xuemei & John L. Neumeyer. (2007). Kappa Receptor Bivalent Ligands. Current Topics in Medicinal Chemistry. 7(4). 363–373. 26 indexed citations
19.
Peng, Xuemei, Ao Zhang, Nora S. Kula, Ross J. Baldessarini, & John L. Neumeyer. (2004). Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents. Bioorganic & Medicinal Chemistry Letters. 14(22). 5635–5639. 10 indexed citations
20.
Peng, Xuemei, et al.. (2001). Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L.. Carbohydrate Research. 331(1). 95–99. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026